Alpha IVF Group Bhd group managing director Datuk Colin Lee Soon Soo.
PETALING JAYA: Fertility care specialist Alpha IVF Group Bhd sees strong potential in the Indonesian market, as it opens its third facility – the Medan satellite clinic.
It said the plan is part of a structured and phased rollout that saw the group debuting its facility in Jakarta as its operational headquarters in May 2025, followed by a facility in Surabaya in August 2025.
The Indonesian market had been a strategic play by the group – in financial year 2025 oocyte pick-ups (OPUs) from Indonesia accounted for 71.4% of fertility centre Genesis IVF’s total OPUs
Group managing director Datuk Colin Lee Soon Soo said its third facility would further strengthen its regional patient acquisition and referral strategy while extending its front-end presence into North Sumatra, one of Indonesia’s most populous regions as well as Aceh and Riau.
He added the clinic would function as a front-end patient engagement and coordination centre, offering initial fertility consultations, diagnostic assessments, patient education and referral support.
“Patients requiring advanced assisted reproductive treatments will be seamlessly referred to Alpha IVF’s comprehensive centres in Malaysia.
“This integrated model enables the group to expand regional reach, optimise resource utilisation, and preserve high clinical and operational standards, while supporting long-term scalability,” he said in a statement.
According to Lee, the group is approaching the completion of its planned satellite clinic rollout in Indonesia, with a fourth clinic under planning.
The third facility would provide broader geographic coverage, improved patient funnel visibility and enhanced conversion potential.
For instance, the Medan clinic’s geographical proximity to Penang would also support cross-border patient flows into Penang which has seen a steadily increasing contribution from Indonesian patients.
“Each satellite clinic is strategically positioned as a regional access point, strengthening patient engagement while optimising referrals into our core in vitro fertilisation (IVF) centres.
“This capital-efficient model allows us to scale with discipline, maintain clinical consistency, and generate strong visibility on patient conversion, supporting sustainable earnings growth over the medium term,” Lee said.
He also said the new Medan clinic would operate under the clinical leadership of Djamin Kartarino.
According to Lee, Djamin’s extensive clinical experience and strong local reputation are expected to support market penetration, physician referrals, and patient trust.
Besides Indonesia, the group has began operations of its IVF centre in Quezon City, Manila last month.
The centre is reportedly designed to support up to 1,500 procedures annually and will have the capability of a full suite of reproductive services.
Alpha IVF also has offices in China and IVF centres in Singapore.
